A team of Penn researchers are using the HIV virus to cure cancer.
The efforts of Penn Medicine’s Dr. Carl June and his team have been described as a “breakthrough treatment” for leukemia in the New York Times. June’s work is backed in part by a $3 million grant from Richard Vague, the investor who founded early stage investment firm Gabriel Investments and is a large supporter of Fringe Festival and other cultural efforts in the city.
Watch a video about June’s work below.-30-
You can now take a Jefferson course in blockchain for health care
JP Morgan Chase scoops up InstaMed, but the healthcare-tech company isn’t leaving Philly
3 ways the Pennovation Center helps its women entrepreneurs accomplish their goals
How Macquarie blends tech-fueled financial services with global opportunity
NeuroFlow wins pitch competition at HIMSS healthcare conference
Two Philly companies are joining an accelerator inside the ‘largest medical complex in the world’
Science Center just gave $700K to support four local researchers
This apprenticeship program is opening the door for candidates with nontraditional backgrounds
Sign-up for daily news updates from Technical.ly Philadelphia